rs61737294

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000263.4(NAGLU):​c.421T>A​(p.Ser141Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00345 in 1,614,212 control chromosomes in the GnomAD database, including 177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S141F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.019 ( 103 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 74 hom. )

Consequence

NAGLU
NM_000263.4 missense

Scores

2
8
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.63

Publications

2 publications found
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]
NAGLU Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Myriad Women’s Health, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Charcot-Marie-Tooth disease axonal type 2V
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000263.4
BP4
Computational evidence support a benign effect (MetaRNN=0.009859383).
BP6
Variant 17-42537435-T-A is Benign according to our data. Variant chr17-42537435-T-A is described in ClinVar as Benign. ClinVar VariationId is 235755.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0658 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000263.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGLU
NM_000263.4
MANE Select
c.421T>Ap.Ser141Thr
missense
Exon 2 of 6NP_000254.2A0A140VJE4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGLU
ENST00000225927.7
TSL:1 MANE Select
c.421T>Ap.Ser141Thr
missense
Exon 2 of 6ENSP00000225927.1P54802
NAGLU
ENST00000963429.1
c.499T>Ap.Ser167Thr
missense
Exon 2 of 6ENSP00000633488.1
NAGLU
ENST00000904921.1
c.478T>Ap.Ser160Thr
missense
Exon 3 of 7ENSP00000574980.1

Frequencies

GnomAD3 genomes
AF:
0.0195
AC:
2964
AN:
152220
Hom.:
103
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0681
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00706
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00510
AC:
1282
AN:
251452
AF XY:
0.00389
show subpopulations
Gnomad AFR exome
AF:
0.0712
Gnomad AMR exome
AF:
0.00298
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00178
AC:
2601
AN:
1461874
Hom.:
74
Cov.:
29
AF XY:
0.00155
AC XY:
1125
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0637
AC:
2132
AN:
33480
American (AMR)
AF:
0.00353
AC:
158
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000450
AC:
50
AN:
1111998
Other (OTH)
AF:
0.00404
AC:
244
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
159
318
478
637
796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0195
AC:
2966
AN:
152338
Hom.:
103
Cov.:
33
AF XY:
0.0189
AC XY:
1405
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0679
AC:
2824
AN:
41582
American (AMR)
AF:
0.00705
AC:
108
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68018
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
144
288
433
577
721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00289
Hom.:
15
Bravo
AF:
0.0217
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0733
AC:
323
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00634
AC:
770
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
Mucopolysaccharidosis, MPS-III-B (2)
-
-
1
Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.87
D
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.90
D
MetaRNN
Benign
0.0099
T
MetaSVM
Uncertain
-0.084
T
MutationAssessor
Benign
1.4
L
PhyloP100
7.6
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.8
N
REVEL
Pathogenic
0.84
Sift
Benign
0.18
T
Sift4G
Benign
0.11
T
Polyphen
0.97
D
Vest4
0.70
MVP
0.98
MPC
1.1
ClinPred
0.017
T
GERP RS
4.4
PromoterAI
-0.0085
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.61
gMVP
0.94
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737294; hg19: chr17-40689453; API